General
Preferred name
INSULIN DETEMIR
Synonyms
Insulin-detemir ()
Levemir Innolet ()
Detemir ()
Levemir ()
Insulin Detemir Recombinant ()
NN-304 ()
Levemir Penfill ()
Levemir flextouch ()
Ins Levemir ()
Levemir Flexpen ()
Insulin,detemir,human ()
P&D ID
PD071747
CAS
169148-63-4
Tags
drug
Drug indication
Type-1/2 diabetes
Drug Status
approved
Max Phase
Phase 4
First approval
2005
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
4
ChEMBL Approved Drugs
ChEMBL Drugs
DrugMAP
DrugMAP Approved Drugs
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
7
Properties
(calculated by RDKit )
Molecular Weight
5912.79
Hydrogen Bond Acceptors
81
Hydrogen Bond Donors
76
Rotatable Bonds
136
Ring Count
12
Aromatic Ring Count
9
cLogP
-13.38
TPSA
2252.82
Fraction CSP3
0.59
Chiral centers
50.0
Largest ring
81.0
QED
0.01
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Therapeutic Class
Hypoglycemic Agents
Source data
